DRL

DRL posts Q2 FY17 and H1FY17 results

Read more

DRL’s migraine drug ZEMBRACE SymTouch launched in US

Read more

DRL signs MoU with LSSSDC and VIPER

Read more

Sales rep files sexual harassment claims against DRL, Promius Pharma

Read more

DRL Laboratories signs commercialisation deal with Hatchtech

Read more

DRL ink pact with Purdue varsity for drug research

Read more

DRL unveils new corporate brand identity

Read more